Search

everythinglearnresearchcommunity

for

Search:↓

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

PCOS is a long-term condition that needs more research for better understanding and treatment.

Most white Spanish women have a widow's peak, and their hairline measurements could help in hair restoration surgery.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

The article explains how to identify and treat excessive hair growth in women, which can be distressing and may signal other health problems.

PCOS is a major cause of infertility and requires personalized treatment.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

A higher testosterone to dihydrotestosterone ratio may indicate worse metabolic health in women.

Longer GGN repeats in the androgen receptor gene are linked to polycystic ovary syndrome.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

Hirsutism causes significant psychological distress in women.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Early treatment of PCOS is crucial for better health and quality of life.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Stinging nettle has compounds that help with joint pain, arthritis, and prostate issues.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

Androgens can both increase body hair and cause scalp hair loss.